Objective: To investigate the clinical and prognostic values of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer.
Methods: A total of 386 hospitalized patients with stage I ∼ IV breast cancer from Nov 1998 to Feb 2009 were followed up, and their clinicopathological data were analyzed retrospectively to determine the factors affecting their prognosis.
Results: First, preoperative serum CA153 expression level was significantly associated with the age of onset and tumor size (P < 0.05), the expression of serum CEA was correlated with tumor size (P < 0.05), and the expression of serum tissue polypeptide specific antigen (TPS) was correlated with tumor size and lymph node metastases (P < 0.05). Second, the overall survival was significantly shorter among patients with elevated serum CA153, CEA or TPS, respectively (P < 0.05 for overall). Finally, multivariate Cox regression analysis indicated that estrogen receptor status (ER) and elevated preoperative values of CA 153 are independent prognostic factors for overall survival (P < 0.05), and CA 153 is a risk factor but estrogen receptor status is a protective factor for overall survival.
Conclusions: Higher preoperative expression of serum CA153, CEA or TPS is closely correlated with clinicopathological characteristics and overall survival. The prognosis is poorer in primary breast cancer patients with higher CA15-3 expression level, and pre-treatment CA153 expression level can be used as an independent prognostic parameter in patients with primarily breast cancer.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
MUC1 expression is associated with ST3GAL2 and negatively correlated with the androgen receptor in castration-resistant prostate cancer.
Glycoconj J
December 2024
Department of Urology, University of the Ryukyus Graduate School of Medicine, 207 Uehara, Nishihara, Nakagami-gun, Okinawa, 903-0215, Japan.
Stage-specific embryonic antigen-4 (SSEA-4) is a developmentally regulated antigen, while expression level of SSEA-4 and / or its synthase ST3GAL2 is associated with prognosis in various malignancies. We have reported a prominent increase of SSEA-4 in castration-resistant prostate cancer (CRPC) and its negative correlation with the androgen receptor (AR). Meanwhile, loss of AR has increased to approximately 30% with the growing use of androgen receptor signaling inhibitor for metastatic CRPC (mCRPC).
View Article and Find Full Text PDFCombining Water-soluble Porphyrin and Phthalocyanine Photosensitizers with Doxorubicin Improves the Efficacy of Chemo-photodynamic Therapy against DMBA-induced Breast Carcinoma.
Chem Biodivers
December 2024
Egypt-Japan University of Science and Technology, Nanoscience, New Bor El-Arab city, New Bor El-Arab city, EGYPT.
Breast cancer ranks as the second most widespread form of cancer globally. Currently, combination therapy is being actively employed in clinical practice to augment the efficiency of anticancer treatment. Hence, the objective of this study was to assess the therapeutic efficacy of a combination of femtosecond laser-based PDT utilizing two distinct photosensitizers (PSs), zinc phthalocyanine tetrasulfonate (ZnPcS4) and meso-tetrakis(4-N-methylpyridyl) porphine (TMPyP) in conjunction with doxorubicin chemotherapeutic agent, on mammary carcinomas experimentally induced in female mice using 7,12-dimethylbenz (a) anthracene (DMBA).
View Article and Find Full Text PDFPredictive value of CA-153, CA-125 and Apo A for ocular metastasis in menopausal female patients with breast cancer.
Int J Ophthalmol
December 2024
Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, China.
Aim: To establish a meaningful standard for diagnosing ocular metastasis (OM) in menopausal breast cancer (BC) women, and explore the relationship between CA-153, CA-125, apolipoprotein A, and OM.
Methods: A total of 1362 menopausal female BC patients with OM volunteered to take part in this study between July 2012 and July 2022. Women with BC who are menopausal were found to have an OM incidence of 1.
Highly efficient electrochemical biosensing platform in breast cancer detection based on MOF-COF@Au core-shell like nanostructure.
Sci Rep
December 2024
Department of Chemistry, Faculty of Science, Yuzuncu Yil University, Van, 65080, Turkey.
Article Synopsis
- Researchers developed a highly sensitive electrochemical biosensor for cancer diagnosis, combining a nanocomposite of MIL-156 MOF@COF with gold (Au) nanoparticles to detect the CA15-3 biomarker.
- The biosensor features a core-shell structure that enhances surface area and conductivity, allowing for effective antibody bonding and improved electrochemical signal amplification.
- Differential pulse voltammetry was employed to demonstrate the biosensor's linear response in CA15-3 detection, successfully distinguishing between breast cancer patients and healthy individuals using serum samples.
Predicting solitary pulmonary lesions in breast cancer patients using fluorodeoxyglucose-positron emission tomography/computed tomography combined with clinicopathological characteristics.
BMC Pulm Med
November 2024
Department of Radiology, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, 230022, China.
Article Synopsis
- The study evaluates how F-FDG-PET/CT imaging combined with clinicopathological factors can help differentiate between primary lung cancer (PLC) and breast cancer metastasis (BCM) in patients with solitary pulmonary nodules (SPNs) following breast cancer treatment.* -
- It involved 120 breast cancer patients, comparing clinicopathological characteristics and imaging features to identify significant differences, particularly in tumor markers and metabolic activities related to SPNs.* -
- Key findings suggest that certain imaging features and serum markers, like SUV and specific signs on CT scans, are predictive factors that can aid in accurately diagnosing SPNs in this patient population.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!